Skip to main content
Caplight Logo









Cenegenics

Cenegenics

Private
Las Vegas, NevadaHealthcare & Life Scienceshttps://cenegenics.com/

Last Round

Growth Equity

May 24, 2022

Total Funding Raised

$23M

Company Overview

Cenegenics is a healthcare company that provides physician-led, proactive, and preventative medical programs focused on age management and longevity.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Healthcare Analytics, Sports & Fitness, Telemedicine

Business Model

B2C

Customer Profile

Services & Consulting, Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

age management medicinelongevity medicineconcierge medicinebioidentical hormone replacementBHRTexecutive healthhealth optimizationbiohackingpreventative medicinepersonalized healthnutraceuticalsperformance optimizationdiagnostic testingwellness program

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cenegenics Comparables

Compare Cenegenics with similar companies based on industry and business-model similarity.

Cenegenics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Human Longevity
85%
Fountain Life
85%
Next Health
82%

Cenegenics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityMay 24, 2022
Buyout/LBOJul 1, 2020
DebtAug 9, 2012

Key People

Founding team and executive leadership

Jorge Arriola

Presidente Y CEO

Executive Team

Mara Fragomeni

CEO Cenegenics Portugal

Executive Team

Cenegenics Investors

Notable investors and investment history

Cenegenics investors
InvestorRounds
AEA InvestorsPrivate Equity, Buyout/LBO
Primetime PartnersGrowth Equity
ROCA PartnersBuyout/LBO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 19, 2026

    Monthly visitors increased 73% MoM.

  • Jan 2, 2026

    Monthly visitors increased 50% MoM, reaching 43K.

Cenegenics Filings

Explore SEC and related filing metadata, where available.

Cenegenics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cenegenics's valuation, stock price, and market status.

Is Cenegenics a public or private company?

Cenegenics is a private company.

What is the current stock price of Cenegenics?

Cenegenics is a private company with no public stock price. Caplight tracks Cenegenics's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Cenegenics worth (valuation)?

Valuation information for Cenegenics is not publicly available.

Can I buy Cenegenics stock?

Cenegenics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cenegenics's last funding round?

Cenegenics's most recent funding round was Growth Equity on May 24, 2022.

Who are the main investors in Cenegenics?

Key investors in Cenegenics include AEA Investors.

Will Cenegenics IPO soon?

No public IPO plans have been announced for Cenegenics.

How can I track Cenegenics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cenegenics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLas Vegas, Nevada
Employee Range198
Year Founded1997
Last FundingMay 24, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?